Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer

Human Pathology

Volumn 43, Issue 11, 2012, Pages 2070-2079

  Asioli, Sofia ^a   Maletta, Francesca ^a   Verdun Di Cantogno, Ludovica ^a   Satolli, Maria A ^b   Schena, Marina ^b   Pecchioni, Carla ^a   Botta, Cristina ^a   Chiusa, Luigi ^a   Molinaro, Luca ^a   Conti, Luca ^a   Viale, Giuseppe ^c   Ingravallo, Giuseppe ^d   Maiorano, Eugenio ^d   Sapino, Anna ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

Gastric cancer; HER2; Immunohistochemistry; Surgical specimen

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROPYRIMIDINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GASTRECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; STOMACH SURGERY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; STOMACH NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84867848639     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.02.017     Document Type: Article

References (20)

1. C. Gravalos, and A. Jimeno HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target Ann Oncol 19 2008 1523 1529
2. M. Tanner, M. Hollmen, and T.T. Junttila Amplification of HER-2 in gastric carcinoma: association with topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab Ann Oncol 16 2005 273 278
3. A.D. Wagner, and M. Moehler Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era Curr Opin Oncol 21 2009 381 385
4. Y.J. Bang, E. Van Cutsem, and A. Feyereislova Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 2010 687 697
5. E. Van Cutsem, M. Dicato, and R. Geva The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010 Ann Oncol 22 2011 1 9
6. J.T. Hsu, T.C. Chen, and J.H. Tseng Impact of HER-2 overexpression/ amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients Oncologist 16 2011 1706 1713
7. H. Grabsch, S. Sivakumar, S. Gray, H.E. Gabbert, and W. Muller HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series Cell Oncol 32 2010 57 65
8. C.B. Moelans, A.N. Milne, F.H. Morsink, G.J. Offerhaus, and P.J. van Diest Low frequency of HER2 amplification and overexpression in early onset gastric cancer Cell Oncol (Dordr) 34 2011 89 95
9. J.E. Boers, H. Meeuwissen, and N. Methorst HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH) Histopathology 58 2011 383 394
10. M. Hofmann, O. Stoss, and D. Shi Assessment of a HER2 scoring system for gastric cancer: results from a validation study Histopathology 52 2008 797 805
11. J. Yang, H. Luo, and Y. Li Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens Cell Biochem Biophys 62 2011 221 228
12. J. Rüschoff, W. Hanna, and M. Bilous HER2 testing in gastric cancer: a practical approach Mod Pathol 2012 1 14
13. G.Y. Lauwers, F. Carneiro, and D.Y. Graham Gastric carcinoma F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise, WHO classification of tumours of the digestive system 2010 IARC Press Lyon, France 48 58
14. J. Ruschoff, M. Dietel, and G. Baretton HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing Virchows Arch 457 2010 299 307
15. C. Marchio, M.B. Lambros, and P. Gugliotta Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis J Pathol 219 2009 16 24
16. N. Goseki, T. Takizawa, and M. Koike Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma Gut 33 1992 606 612
17. E.Y. Lee, M.L. Cibull, W.E. Strodel, and J.V. Haley Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma Arch Pathol Lab Med 118 1994 235 239
18. A.H. Marx, L. Tharun, and J. Muth HER-2 amplification is highly homogenous in gastric cancer Hum Pathol 40 2009 769 777
19. G.H. Vance, T.S. Barry, and K.J. Bloom Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines Arch Pathol Lab Med 133 2009 611 612
20. S. Lee, W.B. de Boer, S. Fermoyle, M. Platten, and M.P. Kumarasinghe Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections Histopathology 59 2011 832 840